by Amy S. Nunn, Lauren Brinkley-Rubinstein, Catherine E. Oldenburg et al.
AIDS: 13 March 2017, Vol. 31, Issue 5, pp. 731–734

4 pp. 244 kB
http://journals.lww.com/aidsonline/Fulltext/2017/03130/Defining_the_HIV_pre_expos
ure_prophylaxis_care.15.aspx

Pre-exposure prophylaxis (PrEP) has demonstrated efficacy in preventing HIV. Whereas PrEP use is expanding globally, there is little consensus about how to measure progress in PrEP care other than to measure the number who initiate and adhere to PrEP and then impute reductions in HIV incidence. Standard benchmarks are necessary in order to compare progress in PrEP programs. The authors draw on more than 4 years of PrEP implementation experience and propose a PrEP care continuum that assesses the multiple steps related to PrEP uptake, adherence, and retention in care.

(Visited 15 times, 1 visits today)
This entry was posted in Essential Medicines, General, HIV - AIDS - STI. Bookmark the permalink.
Facebook Auto Publish Powered By : XYZScripts.com
Get the latest issue of the NewsletterDownload